GL1X · GenesisL1 explorer

Research workbench

Crystal structure of hepatitis C virus NS3 helicase with a novel inhibitor

Analyse Crystal structure of hepatitis C virus NS3 helicase with a novel inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2ZJO
Type
protein
Length
444 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Genome polyprotein
EC
3.4.21.98
UniProt
P29846
Ligands
BHT
Pockets
4 · best druggability 0.55

Structure

x-ray diffraction · 1 distinct chain · 33% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGenome polyprotein (EC 3.4.21.98)protein44433% helix, 20% strandP29846

Ligands and binding sites

  • BHT · N-[4-(bis{4-[(3-sulfophenyl)amino]phenyl}methylene)cyclohexa-2,5-dien-1-ylidene]-4-sulfobenzenaminium · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13370.550.7532empty
2830.340.7518empty
3590.300.7511empty
4630.270.7321empty

Compared structures

  • 2ZJO · Crystal structure of hepatitis C virus NS3 helicase with a novel inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.